longevity biotech startup strategy

longevity biotech startup strategy

Longevity Science vs Traditional Pharma? One Fails

Longevity Science vs Traditional Pharma? One Fails Traditional pharma falls short when it comes to translating aging-biology breakthroughs into market-ready therapies, while agile longevity startups can outpace it by leveraging conference momentum and regulatory shortcuts. I have observed this gap first-hand at multiple ARDD events. Medical Disclaimer: This article is